Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bianca M M Streng

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Gynecologic Oncology|February 25, 2020
The risk of developing squamous cell carcinoma in patients with anogenital lichen sclerosis: A systematic reviewJudith J Spekreijse, Bianca M M Streng, Ravi F M Vermeulen, et al.
Current Opinion in Infectious Diseases|August 6, 2025
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunitiesRuben C A de Groot, Bianca M M Streng, Louis J Bont, et al.
Human Vaccines & Immunotherapeutics|June 1, 2026
T-cell responses to primary SARS-CoV-2 vaccination in Down syndrome - From childhood to adulthoodLobke C M Hensen, Bianca M M Streng, Femke van Wijk, et al.
ERJ Open Research|December 10, 2025
<i>Mycoplasma pneumoniae</i> re-emergence in 2023 causes disease in adults in EuropeBianca M M Streng, Louis J Bont, Patrick M Meyer Sauteur, et al.
Aging Cell|April 15, 2024
IgG1 glycosylation highlights premature aging in Down syndromeBianca M M Streng, Julie Van Coillie, Joanne G Wildenbeest, et al.
The Journal of Infectious Diseases|June 24, 2022
Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down SyndromeBianca M M Streng, Marin Bont, Eveline M Delemarre, et al.
Vaccine|December 25, 2025
Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with Down syndromeBianca M M Streng, Lobke C M Hensen, Eveline M Delemarre, et al.
Human Vaccines & Immunotherapeutics|November 6, 2025
T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome - a prospective cohort studyLobke C M Hensen, Bianca M M Streng, Femke van Wijk, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Gynecologic Oncology|February 25, 2020
The risk of developing squamous cell carcinoma in patients with anogenital lichen sclerosis: A systematic reviewJudith J Spekreijse, Bianca M M Streng, Ravi F M Vermeulen, et al.
Current Opinion in Infectious Diseases|August 6, 2025
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunitiesRuben C A de Groot, Bianca M M Streng, Louis J Bont, et al.
Human Vaccines & Immunotherapeutics|June 1, 2026
T-cell responses to primary SARS-CoV-2 vaccination in Down syndrome - From childhood to adulthoodLobke C M Hensen, Bianca M M Streng, Femke van Wijk, et al.
ERJ Open Research|December 10, 2025
<i>Mycoplasma pneumoniae</i> re-emergence in 2023 causes disease in adults in EuropeBianca M M Streng, Louis J Bont, Patrick M Meyer Sauteur, et al.
Aging Cell|April 15, 2024
IgG1 glycosylation highlights premature aging in Down syndromeBianca M M Streng, Julie Van Coillie, Joanne G Wildenbeest, et al.
The Journal of Infectious Diseases|June 24, 2022
Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down SyndromeBianca M M Streng, Marin Bont, Eveline M Delemarre, et al.
Vaccine|December 25, 2025
Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with Down syndromeBianca M M Streng, Lobke C M Hensen, Eveline M Delemarre, et al.
Human Vaccines & Immunotherapeutics|November 6, 2025
T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome - a prospective cohort studyLobke C M Hensen, Bianca M M Streng, Femke van Wijk, et al.
Pageof 1